{"disease":{"id":"systemic-sclerosis-ssc","name":"systemic sclerosis ssc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06772896","title":"Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":851,"lead_sponsor_name":"Lady Davis Institute","has_results":false},{"nct_id":"NCT06894654","title":"DERMATOMICS: Identifying Regulators of Skin Homeostasis","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Relation Therapeutics","has_results":false},{"nct_id":"NCT07188285","title":"Mass Spectrometry-based Immune Profiling in Autoimmune Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07087912","title":"Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":477,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT07277491","title":"Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity","phase":"","overall_status":"RECRUITING","enrollment_count":460,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT05000216","title":"COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":258,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06308978","title":"A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"Fate Therapeutics","has_results":false},{"nct_id":"NCT07022912","title":"PPI Refractory - GERD Mechanisms in Systemic Sclerosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":147,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT03856853","title":"Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Beijing Continent Pharmaceutical Co, Ltd.","has_results":false},{"nct_id":"NCT06769399","title":"Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT06598982","title":"Investigation of Respiratory Muscle Sarcopenia in Patients With Systemic Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Selcuk University","has_results":false},{"nct_id":"NCT06655155","title":"A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":81,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT06658470","title":"Hand Disability In Systemic Sclerosis - Digital Ulcers","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":72,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT07085676","title":"Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Polina Stepensky","has_results":false},{"nct_id":"NCT06658483","title":"Hand ScleroDerma Lived Experience Scale in Individuals With Systemic Sclerosis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":54,"lead_sponsor_name":"Pamukkale University","has_results":false},{"nct_id":"NCT06594302","title":"Functional Performance and Biopsychosocial Characteristics in Individuals with Systemic Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT04223817","title":"7.0 Tesla Resonance Magnetic Imaging of the Hand in Systemic Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT06794008","title":"BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06588959","title":"6-minute Pegboard Ring Test in Patients With Scleroderma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Yasemin GEDIKLI","has_results":false},{"nct_id":"NCT07292961","title":"Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT07360808","title":"Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Cytori Therapeutics","has_results":false},{"nct_id":"NCT06859567","title":"Chester Step Test: is It Effective in Scleroderma Patients?","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Firat University","has_results":false},{"nct_id":"NCT03482219","title":"Rehabilitation for Arm Coordination and Hand Movement in Systemic Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT06189495","title":"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06822881","title":"CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Beijing GoBroad Hospital","has_results":false},{"nct_id":"NCT07527936","title":"A Study of BEN301 Injection in theTreatment of Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT07535931","title":"A Phase I/Ⅱ Clinical Trial for HS_SW01 Cells Injection in the Treatment of Systemic Sclerosis","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":21,"lead_sponsor_name":"Shenzhen Huishan Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06672822","title":"Intralesional Injection of STS in Treatment of Calcinosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Robyn T. Domsic, MD, MPH","has_results":false},{"nct_id":"NCT07104721","title":"A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06888960","title":"Safety Study of CC312 in Autoimmune Disease Patients","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"CytoCares Inc","has_results":false},{"nct_id":"NCT03222492","title":"Brentuximab Vedotin for Systemic Sclerosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07526350","title":"MTS109 in Patients With Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT07072884","title":"GC012F in Patients With Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Qiong Fu","has_results":false},{"nct_id":"NCT06614270","title":"Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06978647","title":"A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06941129","title":"CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07413341","title":"A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Therorna","has_results":false},{"nct_id":"NCT07212959","title":"As Part of a Pilot Study, Visualization of Inflammatory Activity in Systemic Sclerosis Using CXCR4 PET/CT","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Wuerzburg University Hospital","has_results":false},{"nct_id":"NCT07523282","title":"Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Shenzhen MagicRNA Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT06792344","title":"Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT07184450","title":"Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":11,"lead_sponsor_name":"Chongqing Precision Biotech Co., Ltd","has_results":false},{"nct_id":"NCT07158996","title":"A Study of Cizutamig in Systemic Sclerosis","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT07159009","title":"A Study of GB261 in Systemic Sclerosis","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT07301164","title":"Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06821659","title":"Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06828042","title":"Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06037577","title":"Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"ChemomAb Ltd.","has_results":false}],"total":47},"guidelines":[],"source":"Drug Landscape verified database"}